The pentose phosphate pathway is a central glucose-processing route that runs alongside the more famous energy-producing pathway, glycolysis, but with a fundamentally different purpose. Instead of generating energy currency for the cell, it produces two things cells cannot do without: NADPH, a molecule that powers antioxidant defenses and drives the construction of fats, cholesterol, and other building blocks, and ribose-5-phosphate, the sugar backbone of DNA and RNA.1PubMed Central. The pentose phosphate pathway in health and disease That dual output makes the pathway quietly essential to everything from red blood cell survival and immune cell killing power to cancer growth and even long-term memory formation.
Two Halves, Two Jobs
The pathway splits into two phases, and understanding the division explains most of what the pathway actually does. The first half, called the oxidative phase, is irreversible. Glucose-6-phosphate enters, and three enzyme-driven reactions strip electrons from it, generating NADPH in two of those three steps. The enzymes responsible for the NADPH-producing reactions are glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD).2Biochemical Society Transactions. The enzymes of the oxidative phase of the pentose phosphate pathway as targets of reactive species: consequences for NADPH production The carbon skeleton that comes out the other end is ribulose-5-phosphate, a five-carbon sugar that feeds into the second half.
The second half, the non-oxidative phase, is reversible and acts more like a molecular reshuffling workshop. It rearranges carbon skeletons of varying lengths, converting five-carbon sugars into three-carbon and six-carbon sugars that can re-enter glycolysis or be used elsewhere. This flexibility matters because it lets the cell adjust the ratio of its outputs. When a cell desperately needs NADPH but not ribose, the non-oxidative phase can recycle the five-carbon sugars back into six-carbon glucose-6-phosphate, which loops through the oxidative phase again for more NADPH. When a dividing cell needs huge quantities of ribose for DNA synthesis, the non-oxidative phase can run in the other direction, converting glycolytic intermediates into ribose-5-phosphate without generating any NADPH at all.3PubMed Central. The pentose phosphate pathway and cancer
The Cell’s Antioxidant Currency
NADPH is not itself an antioxidant, but it is the molecule that recharges the cell’s actual antioxidant systems. Glutathione, the cell’s most abundant antioxidant, needs to be constantly recycled from its spent (oxidized) form back to its active (reduced) form. That recycling consumes NADPH. The thioredoxin system, another major line of defense against oxidative damage, also depends on NADPH. Without a steady supply, reactive oxygen species accumulate and damage proteins, lipids, and DNA.
In most cells, the pentose phosphate pathway is the dominant source of this NADPH. Research on antioxidant enzyme networks has shown that NADPH availability is a major rate-controlling factor in how effectively cells scavenge reactive oxygen species, with mitochondrial substrate processing tightly linked to how much NADPH is on hand.4PubMed Central. Compartment-specific Control of Reactive Oxygen Species Scavenging by Antioxidant Pathway Enzymes This means the pentose phosphate pathway is not just one of many contributors to antioxidant defense. It is often the bottleneck that determines whether a cell can protect itself or not.
Building Blocks Beyond Sugar
The pathway’s other major product, ribose-5-phosphate, is the starting material for nucleotide synthesis. Every time a cell divides and copies its DNA, or transcribes a gene into RNA, or uses ATP for energy, ribose-5-phosphate from this pathway is part of what makes those molecules possible. But the biosynthetic contributions do not stop there. NADPH from the pathway also fuels the synthesis of fatty acids, cholesterol, proline (an amino acid critical for collagen), deoxyribonucleotides (the building blocks specifically for DNA), and tetrahydrofolate, a vitamin derivative involved in one-carbon metabolism.1PubMed Central. The pentose phosphate pathway in health and disease
The link between the pathway and fat synthesis is particularly tight in certain cell types. In brain cells called oligodendrocytes, which produce the fatty myelin sheaths that insulate nerve fibers, experimentally dialing down the pentose phosphate pathway with an inhibitor produced a proportional drop in fatty acid and cholesterol production.5Neurochemistry International. Relationship between the pentose-phosphate pathway and the de novo synthesis of fatty acids and cholesterol in oligodendrocyte-enriched glial cultures The pathway, in other words, is not just contributing NADPH to fat-building. It is the supply line that fat-building depends on in those cells.
G6PD Deficiency and Red Blood Cells
The first enzyme in the oxidative phase, G6PD, is the gatekeeper of the entire pathway. It is also the rate-limiting step, meaning its activity largely determines how fast the pathway runs.6PubMed Central. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival G6PD deficiency is the most common enzyme deficiency in humans, affecting hundreds of millions of people worldwide.7PubMed Central. Hemolytic Anemia due to Glucose 6 Phosphate Dehydrogenase Deficiency Triggered by Type 1 Diabetes Mellitus The consequences are most visible in red blood cells.
Red blood cells are uniquely vulnerable because they lack mitochondria and a nucleus. They cannot burn fat for energy or ramp up gene expression to compensate when stressed. The pentose phosphate pathway is essentially their only significant source of NADPH. When G6PD activity is low, red blood cells cannot regenerate enough reduced glutathione to handle oxidative challenges. Certain triggers, including specific drugs (like some antimalarials and sulfonamide antibiotics), fava beans, and infections, overwhelm the weakened defenses and cause red blood cells to rupture. The result is hemolytic anemia, sometimes severe enough to require transfusion. One case report documented hemolytic anemia triggered by the metabolic stress of new-onset type 1 diabetes in a child with previously undiagnosed G6PD deficiency.7PubMed Central. Hemolytic Anemia due to Glucose 6 Phosphate Dehydrogenase Deficiency Triggered by Type 1 Diabetes Mellitus
People with G6PD deficiency are often asymptomatic until they encounter a trigger, which is why many learn about their condition only after an unexpected hemolytic episode. The deficiency is most prevalent in populations from Africa, the Mediterranean, the Middle East, and Southeast Asia. That geographic distribution is not random, and the reason involves a parasite.
Malaria and an Evolutionary Trade-Off
The malaria parasite Plasmodium falciparum spends part of its life cycle inside human red blood cells, and it depends heavily on the pentose phosphate pathway of both its host cell and its own metabolism to survive there. The parasite needs NADPH to handle the oxidative stress generated by digesting hemoglobin. When the host red blood cell is G6PD-deficient, the resulting NADPH shortage creates a hostile environment for the parasite. This provides partial protection against severe malaria.8Biochemical Journal. Glucose-6-phosphate dehydrogenase–6-phosphogluconolactonase: a unique bifunctional enzyme from Plasmodium falciparum
This selective pressure is why G6PD deficiency persists at such high frequencies in malaria-endemic regions despite its costs. It is a classic evolutionary trade-off: a metabolic weakness in red blood cells that makes hemolytic episodes possible also makes the deadliest form of malaria less lethal. The parasite itself has its own version of the pathway’s first two enzymes fused into a single bifunctional protein, called PfGluPho, which has attracted interest as a potential drug target. Inhibiting PfGluPho could disrupt the parasite’s redox balance without affecting the human enzyme, because the two are structurally different enough to allow selective targeting.9PubMed. Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase is a potential drug target
Why Cancer Cells Hijack the Pathway
Rapidly dividing cells face two simultaneous problems: they need enormous quantities of building materials, and their accelerated metabolism generates dangerous amounts of reactive oxygen species. The pentose phosphate pathway addresses both. Ribose-5-phosphate feeds nucleotide production for DNA replication, and NADPH powers both fat synthesis for new membranes and antioxidant defenses to survive the oxidative stress of rapid growth.3PubMed Central. The pentose phosphate pathway and cancer
It is now clear that many tumors have evolved to increase the flow of glucose through the pentose phosphate pathway. Several cancer-promoting mutations, including activation of certain growth signaling networks, increase the expression or activity of pathway enzymes. Alterations in the pathway directly contribute to cancer cell proliferation, survival, and resistance to cell death.10Protein & Cell. Regulation of the pentose phosphate pathway in cancer This has made the pathway an attractive target for cancer therapy. One approach under investigation targets 6PGD, the second NADPH-producing enzyme. A compound called physcion has been shown to inhibit 6PGD activity and suppress the growth of esophageal squamous cell carcinoma cells, and prior work found similar effects against lung, breast, and head and neck cancers.11PubMed Central. Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway
The therapeutic logic is straightforward but requires precision. Blocking the pathway’s NADPH output could strip cancer cells of their antioxidant shield, making them more vulnerable to oxidative damage and potentially to existing drugs. But the pathway is not dispensable in healthy cells either, so any drug that targets it needs to exploit the differences between how cancer cells and normal cells depend on it.
The Immune System’s Oxidative Burst
While most cells use the pentose phosphate pathway to protect themselves from reactive oxygen species, immune cells called neutrophils use it for the opposite purpose: to produce reactive oxygen species intentionally, in enormous quantities, to kill pathogens. When neutrophils engulf a bacterium or fungus, they undergo a metabolic transformation called the oxidative burst. An enzyme called NADPH oxidase consumes NADPH to generate superoxide, a highly reactive molecule that is lethal to microbes trapped inside the cell.
Research has revealed just how dramatic this metabolic shift is. Upon activation, neutrophils switch from a glycolysis-dominant metabolism to what has been described as a “pentose cycle” mode, where essentially all glucose-6-phosphate is diverted into the oxidative pentose phosphate pathway. The normal forward flow through upper glycolysis actually reverses, recycling five-carbon sugars back into glucose-6-phosphate so they can pass through the oxidative phase again for additional NADPH. This reconfiguration maximizes NADPH yield specifically to fuel superoxide production.12PubMed Central. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils
The pathway also plays a role in another arm of the immune system. T cells, which coordinate adaptive immune responses, require the oxidative pentose phosphate pathway for their activation and antitumor activity. Loss of G6PD function impairs T cell activation, connecting the pathway to cancer immunology as well as innate defense.13PubMed Central. Oxidative pentose phosphate pathway is required for T cell activation and antitumor immunity
A Dual Role in the Heart
The pentose phosphate pathway in heart and blood vessel tissue illustrates a tension at the core of its biology. NADPH regenerates the antioxidants glutathione and thioredoxin, which protect cardiac cells from oxidative damage. But the same NADPH also serves as the fuel for NADPH oxidases, enzymes that deliberately produce reactive oxygen species for signaling purposes. Under certain conditions, this signaling tips into genuine oxidative damage. The pathway thus plays a dual role in the cardiovascular system: it can be cardioprotective by maintaining antioxidant defenses, or it can contribute to oxidative injury when NADPH oxidases are overactive.14PubMed. The Role of the Pentose Phosphate Pathway in Cardiovascular Diseases This duality makes blanket statements about the pathway being “good” or “bad” for the heart misleading. Context, specifically which downstream enzymes are consuming the NADPH, determines the outcome.
The Brain and Long-Term Memory
Brain cells are metabolically intense and highly sensitive to oxidative damage, which makes the pentose phosphate pathway critical in neural tissue. Astrocytes, the supportive glial cells that outnumber neurons, run the pathway actively and ramp it up when glucose levels rise, boosting their glutathione reserves and reducing reactive oxygen species production.15PubMed Central. Astroglial pentose phosphate pathway rates in response to high-glucose environments
A more unexpected connection emerged from research on fruit flies. Work on Drosophila demonstrated that after a learning experience that creates a long-term memory, glial cells shuttle glucose to specific neurons in the mushroom body, a brain structure involved in memory. Those neurons do not burn the glucose for energy. Instead, they funnel it into the pentose phosphate pathway. The researchers confirmed that this PPP activity, independent of normal energy metabolism through pyruvate, is required for long-term memory to form.16Cell Reports. Glia-to-neuron glucose shuttling is required for long-term memory formation in Drosophila While this has been shown in flies and not yet confirmed in mammals, it suggests the pathway may be doing far more in the brain than simple housekeeping.
Tissue-Specific Differences
Not every tissue handles the pentose phosphate pathway in the same way. Classic biochemistry work comparing rat liver, uterus, and muscle tissue found that all three ran the non-oxidative phase, but the end products differed. Liver and uterine tissue accumulated the expected sugar phosphate intermediates, while muscle tissue produced glycerol-3-phosphate instead of the usual triose phosphate, and barely accumulated hexose monophosphate at all.17PubMed Central. Catalysis of pentose phosphate pathway reactions by cytoplasmic fractions from muscle, uterus and liver of the rat This makes sense physiologically: muscle has different metabolic priorities than liver. But it also means that generalizations about “what the pathway does” need qualification. The outputs depend on which tissue you are looking at and what enzymes are expressed there.
The Pathway in Plants
Plants add a layer of complexity because they have both a cytosolic and a plastid (chloroplast) version of the pathway, and the two operate somewhat independently. The non-oxidative reactions, involving the enzymes transketolase and transaldolase, appear to be confined to plastids, while certain enzymes of the oxidative branch and some sugar-converting enzymes exist in both compartments.18Plant Physiology. The Plastidic Pentose Phosphate Translocator Represents a Link between the Cytosolic and the Plastidic Pentose Phosphate Pathways in Plants A transporter protein shuttles intermediates between the two compartments to balance supply and demand.
Recent work using isotopic labeling in plants found that the cytosolic oxidative pentose phosphate pathway is active even in the light, acting as a shunt that bypasses part of the Calvin-Benson cycle (the carbon-fixing process of photosynthesis). Interestingly, the stromal (chloroplast interior) version of the pathway did not show this activity under the same conditions.19PubMed. The oxidative pentose phosphate pathway in photosynthesis: a tale of two shunts This overturns an older assumption that the oxidative pentose phosphate pathway is essentially shut off in illuminated plant cells. It turns out the cytosolic copy keeps running, potentially supplying NADPH and carbon skeletons even while photosynthesis is in full swing.
An Ancient Chemistry
One of the more striking findings about the pentose phosphate pathway is that it may not have needed enzymes to get started. Researchers reconstructed conditions mimicking the Archean ocean, roughly four billion years ago, using the metal ion concentrations thought to have been present at the time. In that solution, without any biological catalysts, they observed 29 chemical reactions that mirror the interconversions of modern glycolysis and the pentose phosphate pathway. These included the formation of ribose-5-phosphate (the nucleic acid precursor) and erythrose-4-phosphate (an amino acid precursor). The reactions were especially sensitive to ferrous iron, which was abundant in early oceans.20PubMed Central. Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible Archean ocean The implication is that the chemistry cells now use for central carbon metabolism may predate life itself, with enzymes evolving later to accelerate and regulate reactions that were already happening spontaneously in iron-rich water.
Aging, Stem Cells, and the Pathway’s Decline
As cells age, multiple metabolic systems slow down, and the pentose phosphate pathway is no exception. Research on stem cell senescence has found that glycolysis, mitochondrial energy production, and the pentose phosphate pathway are all attenuated in aged stem cells, and these metabolic declines represent potential targets for reversing or slowing the aging process in those cells.21PubMed. Metabolic Regulation: A Potential Strategy for Rescuing Stem Cell Senescence If the pathway’s NADPH output drops, antioxidant capacity drops with it, and the cell becomes progressively less able to repair oxidative damage. Whether boosting PPP activity in aged stem cells could meaningfully delay tissue aging is still an open question, but the pathway’s decline is clearly part of the metabolic landscape of growing old.
Measuring the Pathway in Living Cells
One reason the pentose phosphate pathway has historically received less attention than glycolysis or mitochondrial metabolism is that it is harder to measure. The non-oxidative phase shares intermediates with glycolysis, making it difficult to tell which pathway produced a given molecule. Modern approaches use isotope-labeled glucose, feeding cells glucose molecules tagged with carbon-13 at specific positions, and then tracking where the label shows up. The position of the label in downstream metabolites reveals which pathway processed the glucose.
Evaluation of different tracer strategies has found that glucose labeled at the first and second carbon positions provides the most precise estimates for both glycolysis and the pentose phosphate pathway simultaneously.22PubMed Central. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells More recent work has combined multiple differently labeled glucose tracers in parallel experiments to map the direction and magnitude of flux through each branch of the pathway, achieving precision that earlier single-tracer approaches could not.23PubMed Central. Bayesian 13C-Metabolic Flux Analysis of Parallel Tracer Experiments in Granulocytes These methodological advances are part of why the pathway’s roles in immune cells, cancer, and brain metabolism have come into sharper focus only in the past decade or so. The biology was always there; the tools to see it clearly were not.